Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

There’s a reason the Mediterranean diet is considered the gold standard for not only weight loss but an overall healthy ...

Eli Lilly won approval for its tirzepatide under the names Mounjaro for type 2 diabetes and Zepbound for weight loss -- in ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

The UK’s medicines regulator has approved a stronger dose of the weight loss jab Wegovy as demand for the drug is set to soar ...

Novo Nordisk (NYSE: NVO) was once the top player in the weight loss drug market. The company's medicine, Wegovy, practically ...

For weight loss, walking at a moderate pace for 30-45 minutes per day, or 150 minutes per week, is generally recommended and ...

Weight-loss experts reveal their major predictions for 2026, from advanced GLP-1 treatments to AI-driven personalized therapy ...

Embody, a new sister site to WebMD, “focuses on sustainable change — backed by clinicians and supported by a community that ...

Low-carb diets offer flexibility with 20-120 grams of carbs, which controls appetite and energy. Keto limits carbs to 20-50 ...